Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy.
about
Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and UsesRecent Advances in Stimuli-Responsive Release Function Drug Delivery Systems for Tumor TreatmentPolydatin protects the respiratory system from PM2.5 exposureCytocompatible and multifunctional polymeric nanoparticles for transportation of bioactive molecules into and within cellsStimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer.Zero-valent Fe confined mesoporous silica nanocarriers (Fe(0) @ MCM-41) for targeting experimental orthotopic glioma in rats.Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer.Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines.808-nm-Light-Excited Lanthanide-Doped Nanoparticles: Rational Design, Luminescence Control and Theranostic Applications.Breakable mesoporous silica nanoparticles for targeted drug delivery.Organosilica hybrid nanomaterials with a high organic content: syntheses and applications of silsesquioxanes.The Architecture and Function of Monoclonal Antibody-Functionalized Mesoporous Silica Nanoparticles Loaded with Mifepristone: Repurposing Abortifacient for Cancer Metastatic Chemoprevention.NIR-Responsive Polycationic Gatekeeper-Cloaked Hetero-Nanoparticles for Multimodal Imaging-Guided Triple-Combination Therapy of Cancer.Cyanine-Anchored Silica Nanochannels for Light-Driven Synergistic Thermo-Chemotherapy.Biomimetic synthesis of proline-derivative templated mesoporous silica for increasing the brain distribution of diazepam and improving the pharmacodynamics of nimesulide.Self-Assembled Nanoparticles from Phenolic Derivatives for Cancer Therapy.Supramolecular chemotherapy based on host-guest molecular recognition: a novel strategy in the battle against cancer with a bright future.Ultrasound-Triggered Destruction of Folate-Functionalized Mesoporous Silica Nanoparticle-Loaded Microbubble for Targeted Tumor Therapy.Controlled synthesis and size effects of multifunctional mesoporous silica nanosystem for precise cancer therapy.Evaluation of mesoporous silica nanoparticles for oral drug delivery - current status and perspective of MSNs drug carriers.Hybrid mesoporous silica nanocarriers with thermovalve-regulated controlled release.Silicon-based nanotheranostics.Enhanced biosafety of silica coated gadolinium based nanoparticles.Controllably Switched Drug Release from Successively Dual-Targeted Nanoreservoirs.Mesoporous silicate nanoparticles/3D nanofibrous scaffold-mediated dual-drug delivery for bone tissue engineering.N-Doped graphene quantum dot@mesoporous silica nanoparticles modified with hyaluronic acid for fluorescent imaging of tumor cells and drug delivery.Nanoparticle-based targeted cancer strategies for non-invasive prostate cancer intervention.Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer.
P2860
Q28071773-6F549BDD-0A17-42A1-B3E9-5955CA1D833AQ28078974-6152AD02-F1F0-4677-99B5-309DEA498669Q28397853-2A0ADBDF-17F6-47DC-8DC3-7654C8CF7779Q28821307-3BB699D2-2E94-493B-B282-6BB77F1F1460Q33635355-5B0EEA01-FDFC-4136-92AA-AB378C89D2A4Q37076642-0F28383D-62AD-4988-B7BC-5D777EC45056Q38665073-EF6D669B-B46A-4C42-94B5-35B72BE19215Q38676164-F0487B66-FAD4-4E58-A1CA-2C27326EC2F3Q38744965-53F1573C-1B61-477A-9E2E-1761977079DAQ38786580-D3814ECC-3EF1-419F-8AF7-E566BE998054Q39023379-CC9BF3AC-7316-4305-A0F4-F7CD9AAC85AFQ39878482-C3802B8C-E3DF-4784-8741-AF89474CECEAQ45863079-BB5FDA14-8311-4CB4-96C9-6F618E0A495DQ46455544-5FFF4EBA-2441-452C-B2C7-6408294C171DQ47267991-4327DC78-0CDC-4273-AADF-3E95B94CFC5BQ47566089-461EC28D-46AE-48FC-B8F1-170FC96D6906Q47599299-BF2514F6-6C80-40BB-BDB3-DBB06A1CC62EQ47964947-64FD45DC-33E9-45F9-9807-B359AC3027DCQ48242260-90EF1924-6B8B-439F-8DC7-088F69B85A44Q49560705-002BF8AC-2722-4D60-B933-9B3D3C39914FQ50237177-EACB1F81-17FF-4318-A869-BE7E57AEFD1AQ50275652-DEFFD0D7-52FB-4DDB-BC00-10872E35384EQ51017249-FE19EE16-E310-4B34-9060-15D77CBC1B7EQ51081570-F3A7223B-3C14-439C-B048-FF01C44154C7Q52591668-5E45D9AE-FFB2-4575-88E5-0135C7B481D8Q52623839-F6636C0F-E2BB-4051-B7B1-F4F4A0051050Q52718880-71F0C5B1-9A11-46CD-B55F-1B7E0E2A8B1BQ55228197-EF7BDC91-ECEC-4F6B-8CBB-1C5C4ED0F72B
P2860
Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Development of mesoporous sili ...... capability for cancer therapy.
@ast
Development of mesoporous sili ...... capability for cancer therapy.
@en
type
label
Development of mesoporous sili ...... capability for cancer therapy.
@ast
Development of mesoporous sili ...... capability for cancer therapy.
@en
prefLabel
Development of mesoporous sili ...... capability for cancer therapy.
@ast
Development of mesoporous sili ...... capability for cancer therapy.
@en
P2860
P1476
Development of mesoporous sili ...... capability for cancer therapy
@en
P2093
Fuyuhiko Tamanoi
P2860
P356
10.1016/J.ADDR.2015.09.009
P407
P577
2015-10-03T00:00:00Z